(PharmaNewsWire.Com, October 09, 2017 ) ReportsWeb.com has announced the addition of the “Global ANTI-INFECTIVE VACCINES Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Global Anti- infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016 - 2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.
According to Publisher research report, "Global Anti-Infective Vaccines Market - Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)", Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 - 2021.
Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines. Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programs for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.
Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions. While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programs by various NGO's.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
